These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2086712)

  • 1. Bacterial and fungal contaminations in parenteral nutrition admixtures.
    Jirapinyo P; Boonnanakijsin S; Chaiprasert A; Eungprabhanth S
    J Med Assoc Thai; 1990 Dec; 73(12):658-61. PubMed ID: 2086712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
    Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contamination of intravenous fluids by bacteria and fungi during preparation and administration.
    Deeb EN; Natsios GA
    Am J Hosp Pharm; 1971 Oct; 28(10):764-7. PubMed ID: 5001472
    [No Abstract]   [Full Text] [Related]  

  • 4. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of bacteria and fungi in total nutrient admixtures.
    Scheckelhoff DJ; Mirtallo JM; Ayers LW; Visconti JA
    Am J Hosp Pharm; 1986 Jan; 43(1):73-7. PubMed ID: 3082195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of infections from intravenous infusions.
    Med Lett Drugs Ther; 1973 Dec; 15(26):105-7. PubMed ID: 4203094
    [No Abstract]   [Full Text] [Related]  

  • 7. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 8. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: considerations for nosocomial mortality.
    Macías AE; Muñoz JM; Bruckner DA; Galván A; Rodríguez AB; Guerrero FJ; Medina H; Gallaga JC; Cortés G
    Am J Infect Control; 1999 Jun; 27(3):285-90. PubMed ID: 10358234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid peroxidation assessment by malondialdehyde measurement in parenteral nutrition solutions for newborn infants: a pilot study.
    Picaud JC; Steghens JP; Auxenfans C; Barbieux A; Laborie S; Claris O
    Acta Paediatr; 2004 Feb; 93(2):241-5. PubMed ID: 15046281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of airborne microflora in a hospital ward within a period of one year.
    Augustowska M; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(1):99-106. PubMed ID: 16841880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen-calorie ratio during total parenteral nutrition in 1001 surgical patients treated in intensive care unit.
    Harju E; Pessi TT
    Chir Ital; 1985 Aug; 37(4):429-37. PubMed ID: 3935340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of two approaches to parenteral nutrition in critically ill children.
    Gamsjäger T; Brenner L; Schaden E; Sitzwohl C; Weinstabl C
    Pediatr Crit Care Med; 2009 Mar; 10(2):163-5. PubMed ID: 19188880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution.
    Tresoldi AT; Padoveze MC; Trabasso P; Veiga JF; Marba ST; von Nowakonski A; Branchini ML
    Am J Infect Control; 2000 Jun; 28(3):258-61. PubMed ID: 10840347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications--Brazil, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jul; 47(29):610-2. PubMed ID: 9699810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious complications in infusion therapy].
    Daschner F
    Klin Anasthesiol Intensivther; 1977; (14):121-6. PubMed ID: 412006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipids in total parenteral nutrition: instrumentation and bacterial contamination].
    Impieri M; Franceschini L; Briglia R; Giannini S; Defranchi PG; Veneroso A; Belloni E; Pera M
    Minerva Chir; 1987 Nov; 42(21):1755-6. PubMed ID: 3122104
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new amino acid solution for parenteral nutrition of premature infants, newborn infants and infants].
    Pohlandt F; Wagner M; Rhein R; Obladen M
    Infusionstherapie; 1990 Feb; 17(1):40-6. PubMed ID: 2110934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiological control in parenteral nutrition mixtures. Indices of contamination].
    Ginés Rubió F; Puigventós Latorre F; Escrivá Torralva A; Alvarez Rabanal MV; Noguera Picornell MA
    Nutr Hosp; 1993; 8(5):306-10. PubMed ID: 8334183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.